IJGC conversations

ijgcgroup
  • 0,0 (0)
  • MÉDECINE

The International Journal of Gynecological Cancer (IJGC) conversations is a podcast that brings you the latest insights into gynecologic malignancies. Tune in to engaging conversations with leading experts as they explore innovative and timely topics shaping the field. Hosted by the Editor-in-Chief Dr. Pedro Ramirez and special guests, each episode offers a dynamic and educational experience designed for clinicians, researchers, and anyone passionate about advancing gynecologic cancer care. Subscribe today or stream on your favorite podcast platform. IJGC - https://www.sciencedirect.com/journal/international-journal-of-gynecological-cancer - proudly serves as the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.

  1. -5 J

    GLP1-Receptor Agonists in Endometrial Cancer

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Vivek Podder and Brian M. Slomovitz to discuss GLP1-Receptor Agonists in Endometrial Cancer.   Vivek Podder, MBBS, is an oncology research fellow at Mount Sinai Medical Center in Miami, where he works in gynecologic oncology with a focus on translational research and clinical trials. His work spans molecular oncology, precision medicine, and outcomes research, with an emphasis on translating genomic and metabolic insights into clinically relevant treatment strategies. His research focuses on obesity-associated cancers and the role of metabolic pathways in cancer progression and treatment response, including the potential application of GLP-1 receptor agonists in oncology. He has also contributed to molecular classification and therapeutic stratification in endometrial cancer, including work on homologous recombination deficiency, as well as immunotherapy rechallenge and chemotherapy-free treatment strategies in low-grade serous ovarian carcinoma. His work reflects a consistent effort to translate biological insights into clinical practice. Dr. Podder has authored over 120 peer-reviewed publications, book chapters, and conference abstracts, along with more than 200 evidence summaries, with over 33,500 citations. He has presented his work at major international oncology meetings, including ASCO, ESMO, and SNO. He has contributed to five editions of the First Aid for the USMLE Step 1 and Step 2 CK series, widely regarded as essential resources for medical trainees, and serves as an associate editor and peer reviewer for several leading journals. His work has been recognized internationally, including selection to Stanford University’s list of the world’s top 2% scientists.   Dr. Slomovitz is a Gynecologic Oncologist at Mount Sinai Medical Center in Miami Beach, Florida, and Professor of Obstetrics and Gynecology at the Wertheim College of Medicine at Florida International University. He is an internationally recognized leader in gynecologic oncology clinical trials, specifically in immunotherapy and novel biomarker therapeutics. He also is a leader in sentinel lymph node detection for gynecologic malignancies.

    39 min

  2. 20 AVR.

    Mentor's Podcast: Mario M. Leitao, Jr.

    In this episode of the IJGC podcast, the IJGC editorial fellows are joined by Dr. Mario M. Leitao, Jr. Dr. Mario M. Leitao, Jr., MD, FACOG, FACS, is currently an Attending Surgeon in the Department of Surgery at Memorial Sloan Kettering Cancer Center and a Professor in the Department of Obstetrics and Gynecology at Weill Cornell Medical College. He currently serves as Program Director for the Gynecologic Oncology Fellowship. Dr. Leitao is also the Director for the Minimal Access and Robotic Surgery Program in the Department of Surgery for MSKCC. Dr. Leitao is the recipient of the 2025 IGCS Excellence in Teaching Award.

    1 h 25 min

  3. 6 AVR.

    Topical Treatments for HPV: Fact or Flawed Science

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. René Pareja to discuss Topical Treatments for HPV: Fact or Flawed Science.   Dr. René Pareja is a Gynecologist and Obstetrician, graduated from Universidad Pontificia Bolivariana in Medellín, Colombia in 2000; he finished his training in Gynecologic Oncology in 2003, from Pontificia Universidad Javeriana and Instituto Nacional de Cancerología in Bogotá, Colombia. He is a minimally invasive surgeon, graduated from Corporación de Estudios de la Salud (CES) in 2013. He currently works at Astorga Oncology Clinic in Medellín and at National Cancer Institute in Bogotá, Colombia. Dr. Pareja serves as a reviewer for more than 20 journals. He has authored or co-authored ten book chapters and more than 160 publications in peer-reviewed journals. Currently he is an Associate Editor of the International Journal of Gynaecological Cancer. He also serves as an international mentor for the Hospital General San Juan de Dios in Guatemala through the IGCS Global Curriculum & Mentorship Program. Some of his research has influenced how gynecologic oncologists treat cancer and has been published in important medical journals, like the New England Journal of Medicine, and Journal of Clinical Oncology.

    22 min

  4. 31 MARS

    Molecular Profile-Based Adjuvant Treatment Endometrial Cancer: PORTEC-4a

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Anne-Sophie van den Heerik and Carien Creutzberg to discuss Molecular Profile-Based Adjuvant Treatment Endometrial Cancer: PORTEC-4a.   Anne-Sophie van den Heerik, MD, is a resident in radiation oncologist at the Leiden University Medical Center, The Netherlands. Her work focuses on the integration of molecular classification into endometrial cancer adjuvant therapy decision-making. Her recent publications includes the PORTEC-4a trial and the Cost-utility-analysis of molecular-integrated-profile for women with (high) intermediate risk endometrial cancer - PORTEC-4a an international, randomised, phase 3 trial. Carien Creutzberg, MD, PhD is Professor of Radiation Oncology at Leiden University Medical Center, The Netherlands. Her work focuses on improving outcomes and quality of life for women with gynaecological cancers, particularly endometrial cancer. She is the principal investigator of the landmark PORTEC trials, which have shaped international treatment guidelines, and is a leading figure in integrating molecular profiling into personalized cancer care.

    34 min

  5. 16 MARS

    Pembrolizumab and weekly paclitaxel for platinum-resistant ovarian cancer

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Robert Wenham and Angeles Alvarez Secord to discuss Pembrolizumab and weekly paclitaxel for platinum-resistant ovarian cancer.   Dr. Robert Wenham is a gynecologic oncologist and Chair of the Gynecologic Oncology Program at Moffitt Cancer Center.  Dr. Wenham has a strong interest in research and is a principal investigator for numerous clinical trials to improve cancer care for women.  His research activities include the use of novel drugs for the treatment of gynecologic cancers.  He has received the Molly Cade Ovarian Cancer Research Award from the Gynecologic Cancer Foundation.  Dr. Wenham enjoys the challenge of helping women with complex issues and the opportunity to offer them cutting-edge therapies, from the latest chemotherapy approaches to biologically targeted therapies, minimally invasive surgery, and clinical trials.  He is also an expert in pelvic exenteration surgery, a very complex operation that offers hope of a possible cure for certain patients with gynecologic cancer.  Clinically, he prefers a more collaborative approach where the patient plays an active role in decisions as he guides them through the pros and cons of their options.     Angeles Alvarez Secord, MD, MHSc, is a professor in the Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Duke University Heath System. She received her undergraduate degree with honors from Carroll College in Helena, Montana and graduated AOA with honors from the University of Washington School of Medicine in Seattle, Washington. Dr. Secord completed her residency in obstetrics and gynecology and her fellowship in gynecologic oncology at the Duke University Medical Center in Durham, North Carolina. Upon completing her fellowship in 2001, she joined the Division of Gynecologic Oncology at Duke. She is currently Director of Gynecologic Oncology Clinical Trials, Associate Director of Clinical Research, Gynecology Oncology, and one of the Principal Investigators for NRG Oncology at the Duke Cancer Institute. Dr. Secord serves on the GOG Foundation Board of Directors. She is passionate about mentoring the next generation of investigators and serves as the GOG Foundation Education and Mentoring Chair and the NRG Oncology Investigator and Career Development Committee Vice-Chair. Dr. Secord is a fellow of the American College of Obstetricians and Gynecologists and an active member of American Society of Clinical Oncology, American Gynecological & Obstetrical Society, Society of Gynecology & Oncology, and International Gynecologic Cancer Society as well as other professional organizations.

    44 min

  6. 9 MARS

    Risk-reducing Salpingectomy with Delayed Oophorectomy

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Roni Nitecki Wilke to discuss Risk-reducing Salpingectomy with Delayed Oophorectomy.   Dr. Nitecki Wilke is a gynecologic oncologist and assistant professor at the department of gynecologic oncology and reproductive medicine at the University of Texas MD Anderson Cancer Center.

    24 min

  7. 2 MARS

    De-escalation in Gynecologic Oncology

    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Alex Melamed and René Pareja to discuss De-escalation in Gynecologic Oncology.   Alex Melamed, MD, MPH, is a gynecologic oncologist and clinical outcomes researcher in the Department of Obstetrics and Gynecology at Mass General Hospital and an Associate Professor at Harvard Medical School. He co-directs the Inference Lab in MGH's Vincent Department of Obstetrics and Gynecology. Dr. Melamed's research focuses on applying methods that provide meaningful insights from observational data. In particular, his work explores how focusing on temporal and spatial variation in clinical practice can help to uncover how health care affects patient outcomes. Some of his research focuses on increasing understanding of how surgical care affects the lives of cancer patients. Dr. Melamed is an associate editor of the International Journal of Gynecologic Cancer.    Dr. René Pareja is a Gynecologist and Obstetrician, graduated from Universidad Pontificia Bolivariana in Medellín, Colombia in 2000; he finished his training in Gynecologic Oncology in 2003, from Pontificia Universidad Javeriana and Instituto Nacional de Cancerología in Bogotá, Colombia. He is a minimally invasive surgeon, graduated from Corporación de Estudios de la Salud (CES) in 2013. He currently works at Astorga Oncology Clinic in Medellín and at National Cancer Institute in Bogotá, Colombia. Dr. Pareja serves as a reviewer for more than 20 journals. He has authored or co-authored nine book chapters and more than fifty publications in peer-reviewed journals. Currently he is an Associate Editor of the International Journal of Gynaecological Cancer and is a Council member of the International Gynecological Cancer Society Council. He also serves as an international mentor for the Hospital General San Juan de Dios in Guatemala through the IGCS Global Curriculum & Mentorship Program.Some of his research has influenced how gynecologic oncologists treat cancer and has been published in important medical journals, like the New England Journal of Medicine, JAMA, and Journal of Clinical Oncology.

    40 min

  8. 24 FÉVR.

    Mentor's Podcast: Reitan Ribeiro

    In this episode of the IJGC podcast, the IJGC editorial fellows are joined by Dr. Reitan Ribeiro. Dr. Ribeiro is an Assistant Professor in the Department of Obstetrics & Gynecology and the Department of Oncology at McGill University. He is an attending Gynecologic Oncologist and Surgical Oncologist at the Cedars Cancer Center, McGill University Health Center, where he practices as both a clinician and scientist. A pioneer in laparoscopic and robotic surgery, Dr. Ribeiro developed the uterine transposition technique, enabling fertility preservation for patients undergoing pelvic radiation therapy. His work has earned national and international recognition, and he has shared his technique with oncologists worldwide, teaching it at prestigious cancer centers such as the Houston Methodist Hospital (USA), and international societies such as the European Society of Gynecological Oncology (ESGO). He has also led landmark clinical trials in the field of gynecology oncology, including Keynote 001, LACC, and SGNTV-003. His contributions have been recognized with several prestigious awards, including an Honorable Mention from the Chamber of Deputies of Paraná, Brazil, and the National Medical Treatment Innovation Award (VEJA), best video award from the American Society of Gynecology Oncology (SGO), and the 2025 Outstanding Achievement in Gynecologic Oncology Surgery Award by the International Gynecologic Cancer Society (IGCS) .

    51 min
Tout afficher (72)

À propos

The International Journal of Gynecological Cancer (IJGC) conversations is a podcast that brings you the latest insights into gynecologic malignancies. Tune in to engaging conversations with leading experts as they explore innovative and timely topics shaping the field. Hosted by the Editor-in-Chief Dr. Pedro Ramirez and special guests, each episode offers a dynamic and educational experience designed for clinicians, researchers, and anyone passionate about advancing gynecologic cancer care. Subscribe today or stream on your favorite podcast platform. IJGC - https://www.sciencedirect.com/journal/international-journal-of-gynecological-cancer - proudly serves as the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.

Informations

  • Création
    ijgcgroup
  • Années d’activité
    2024 - 2026
  • Épisodes
    72
  • Classification
    Tous publics
  • Copyright
    © Copyright 2024 All rights reserved.
  • Site web de l’émission
    IJGC conversations

Vous aimeriez peut‑être aussi